Xiaomin He

发表

Home-based Anti-Tuberculosis Treatment Adverse Reactions (HATTAR) study: a protocol for a prospective observational study

Hong-gang Yi, H. Pan, B. Tao, 2019, BMJ Open.

Whole-Exome Sequencing Identified Genes Responsible for Thoracic Aortic Aneurysms and Dissections in three Chinese Families

Jian Dong, Xiaomin He, Jian Zhou, 2022, Frontiers in Genetics.

Association between NR1I2 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population: A case-control study.

Hong-gang Yi, H. Pan, Miaomiao Yang, 2020, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

The A/A Genotype of XPO1 rs4430924 Is Associated With Higher Risk of Antituberculosis Drug‐Induced Hepatotoxicity in Chinese Patients

Hong-gang Yi, H. Pan, Haiping Zhang, 2019, Journal of clinical pharmacology.

The role of the genetic variant FECH rs11660001 in the occurrence of anti‐tuberculosis drug‐induced liver injury

Hong-gang Yi, H. Pan, Lihuan Lu, 2022, Journal of clinical pharmacy and therapeutics.

A first-in-human phase 1 and pharmacological study of TAS-119, a novel selective Aurora A kinase inhibitor in patients with advanced solid tumours

A. Fasolo, Juanita Lopez, A. Dowlati, 2020, British Journal of Cancer.

Relevance of NAT2 genotype to anti‐tuberculosis drug‐induced hepatotoxicity in a Chinese Han population

Hong-gang Yi, H. Pan, B. Tao, 2019, The journal of gene medicine.

Association between genetic polymorphisms of NRF2, KEAP1, MAFF, MAFK and anti-tuberculosis drug-induced liver injury: a nested case-control study

H. Pan, S. Zhan, Ru Chen, 2019, Scientific Reports.

Association of FAM65B, AGBL4, and CUX2 genetic polymorphisms with susceptibility to antituberculosis drug-induced hepatotoxicity: validation study in a Chinese Han population

Hong-gang Yi, H. Pan, B. Tao, 2019, Pharmacogenetics and genomics.

Genetic polymorphisms of UGT1A1 and susceptibility to anti-tuberculosis drug-induced liver: A RUCAM-based case–control study

H. Pan, B. Tao, Miaomiao Yang, 2018, International Journal of Immunopathology and Pharmacology.

A validation study of the UGT1A4 rs2011404 variant and the risk of anti‐tuberculosis drug‐induced hepatotoxicity in an Eastern Chinese Han population

Hong-gang Yi, H. Pan, Miaomiao Yang, 2021, Journal of clinical pharmacy and therapeutics.

Haem oxygenase-1 and haemopexin gene polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity in China.

Hong-gang Yi, H. Pan, Shaowen Tang, 2022, Pharmacogenomics.

Planned Interim Analysis of a Phase 2 Study of Loncastuximab Tesirine Plus Ibrutinib in Patients with Advanced Diffuse Large B-Cell Lymphoma (LOTIS-3)

P. Zinzani, C. Carlo-Stella, A. Ervin‐Haynes, 2021, Blood.

Relationship between common telomere length‐related genetic variations, telomere length, and risk of antituberculosis drug‐induced hepatotoxicity in Chinese Han population: As assessed for causality using the updated Roussel Uclaf Causality Assessment Method

Hong-gang Yi, H. Pan, Lihuan Lu, 2023, Fundamental & clinical pharmacology.